Results 161 to 170 of about 4,210,891 (389)

Response of Medical Cannabis (Cannabis sativa L.) Genotypes to K Supply Under Long Photoperiod [PDF]

, 2019
Avia Saloner, Mollie Sacks, Nirit Bernstein   +2 more
openalex   +1 more source

The effect of medical cannabis laws on juvenile cannabis use

International Journal of Drug Policy, 2016
A number of states in the United States legally allow the use of cannabis as a medical therapy to treat an illness or to alleviate symptoms. Concern persists as to whether these types of laws are increasing juvenile recreational cannabis use. It is also plausible that medical cannabis laws engender an escalation of illicit non-cannabis drug use among ...
Lisa, Stolzenberg, Stolzenberg, Lisa, D’Alessio, Stewart J., Dariano, Dustin   +3 more
openaire   +3 more sources

Drug decriminalization and policy alienation among frontline police in British Columbia: A qualitative study

Criminology &Public Policy, EarlyView.
Abstract Research Summary This qualitative study examines how frontline police officers in British Columbia experienced and adapted to Canada's first formal drug decriminalization policy 1 year after implementation. Drawing on 30 semi‐structured interviews and using thematic analysis with a policy alienation and street‐level bureaucracy lens, we ...
Sarah Ferencz, Alissa Greer, Amanda Butler   +2 more
wiley   +1 more source

Never say never

Journal of Hospital Medicine, EarlyView.
Gurpreet Dhaliwal, Jagmeet Dhingra, Tom Fraser, Leal Herlitz, James Pile   +4 more
wiley   +1 more source

Clinically Significant Neuroimaging Findings Among Pediatric Patients Presenting to the Emergency Department With Symptoms of Psychosis: A Multicenter Retrospective Study

Academic Emergency Medicine, EarlyView.
ABSTRACT Background The clinical utility of diagnostic neuroimaging for pediatric patients presenting to the emergency department (ED) for psychosis remains unclear. We sought to estimate the prevalence of and characteristics associated with clinically significant neuroimaging findings among pediatric patients presenting to the ED with symptoms of ...
Jennifer A. Hoffmann, Tapan K. Parikh, Doug Lorenz, Michael P. Goldman, Emily M. Powers, Shilpa J. Patel, Ilana S. Lavina, Theodore W. Heyming, Jasmin T. England, Mohsen Saidinejad, Ilene Claudius, Pallavi Ghosh, Daniel J. Shapiro, Tricia B. Swan, Kamali L. Bouvay, Eileen Murtagh Kurowski, Nadine M. Smith, Justin R. Davis, Alexander B. Moxam, Eli J. Muhrer, Rohit P. Shenoi, Elyse N. Portillo, Ron L. Kaplan, Neil G. Uspal, Robert M. Lapus, Andrea T. Vo, Daniel B. Fenster, Danielle B. Barrocas, Deborah R. Liu, Pradip P. Chaudhari, Rachel Cafferty, Stephen B. Freedman, Jerri A. Rose, Megan F. Evers, Ashley M. Metcalf, Fareed Saleh, Jennifer Dunnick, Raymond D. Pitetti, Yashas R. Nathani, Muhammad Waseem, Todd A. Florin, on behalf of the Pediatric Emergency Medicine Collaborative Research Committee (PEMCRC) Psychosis Study Group   +41 more
wiley   +1 more source

Negative symptoms as key features of depression among cannabis users: a preliminary report. [PDF]

, 2016
OBJECTIVE: Cannabis use is frequent among depressed patients and may lead to the so-called "amotivational syndrome", which combines symptoms of affective flattening and loss of emotional reactivity (i.e. the so-called "negative" symptomatology). The aim
Albano, G, BERSANI, FRANCESCO SAVERIO, BERSANI, Giuseppe, Caroti, E, Corazza, O., Imperatori, C, MANUALI, GIORGIANA, MINICHINO, AMEDEO, Russo, P, Valeriani, G   +9 more
core  

Legalisation of non-medical cannabis in Canada: will supply regulations effectively serve public health? [PDF]

, 2017
Benedikt Fischer
openalex   +1 more source

Drug Use After Emergency Department‐Initiated Injectable Buprenorphine: A Secondary Analysis of the ED‐INNOVATION Ancillary Safety and Feasibility Trial

Academic Emergency Medicine, EarlyView.
ABSTRACT Study Objective To characterize opioid and nonopioid drug use in the week following emergency department (ED)‐initiated extended‐release buprenorphine (XR‐BUP) treatment using both self‐reported data and urine drug screens (UDS). Methods This study uses data collected during a nonrandomized clinical trial of patients with untreated opioid use ...
Ethan Cowan, Gail D'Onofrio, Jeanmarie Perrone, Erik Anderson, James Dziura, Kathryn Hawk, Andrew Herring, Ryan McCormack, Manali Phadke, Elizabeth A. Samuels, David A. Fiellin   +10 more
wiley   +1 more source

Effects of cannabidiol in alcohol use disorder patients with and without co‐occurring post‐traumatic stress disorder: Tolerability but no evidence for efficacy in two randomized proof‐of‐concept trials

Alcohol, Clinical and Experimental Research, EarlyView.
Two small placebo‐controlled trials evaluated the effects of cannabidiol (CBD) in patients with alcohol use disorder (AUD), with and without co‐occurring post‐traumatic stress disorder (PTSD). CBD was rapidly absorbed and generally well tolerated in dosages of up to 1200 mg/day. Both treatment groups showed large reductions in drinking.
Michael P. Bogenschutz, Esther Blessing, Danielle Dgheim, Dayeon Cho, Jun Zhang, Eugene M. Laska, Charles R. Marmar   +6 more
wiley   +1 more source

Factors Associated with Demand for Medical Cannabis Use among Breast Cancer Patients in Northern Thailand: A Cross-Sectional Study [PDF]

, 2023
Alongkorn Sukrueangkul, Petcherut Sirisuwan, Pariyakorn Sanguankittiphan, Tiwakron Prachaiboon, Kanlayawee Anonjarn, Sumonthip Boonkerd, Yiam Khongruangrat   +6 more
openalex   +1 more source